Evaluating therapeutic vaccines in patients infected with HIV. (Q35851820)

10 August 2017

1 reference

title

Evaluating therapeutic vaccines in patients infected with HIV. (English)

1 reference

10 August 2017

1 reference

1

Brigitte Autran

0 references

Christine Katlama

series ordinal

4

object named as

Christine Katlama

0 references

Dominique Costagliola

series ordinal

2

object named as

Dominique Costagliola

0 references

Robert L. Murphy

object named as

Robert Murphy

series ordinal

3

0 references

publication date

1 August 2004

1 reference

Expert Review of Vaccines

10 August 2017

published in

1 reference

10 August 2017

volume

3

1 reference

10 August 2017

issue

4 Suppl

1 reference

10 August 2017

page(s)

S169-77

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

HIV preferentially infects HIV-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

Therapeutic vaccines against HIV need international partnerships

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

DNA vaccines against human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

Control of HIV despite the Discontinuation of Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S169

10.1586/14760584.3.4.S169

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference